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Given the global tragedy that this most recent pandemic has caused, more attention has been 
given to the devastating outcomes that the spread of infectious disease outbreaks can have. 
Similar to those with comorbid conditions, pregnant women are also extremely vulnerable to 
infectious diseases, as disease manifestation does not only affect the mother, but the fetus as 
well. Thus, the prevention of both the influenza virus and pertussis are two major goals when 
providing care for this population. Preventing both of these disease processes during the 
intrapartum period helps to ensure optimal wellness for both mother and baby and overall limits 
the potential for disease-related complications throughout the lifespan. The purpose of this 
evidence-based practice (EBP) project is to evaluate the effectiveness of a multifaceted 
approach using patient education and reminder/recall interventions to help remind pregnant 
women to receive both their influenza and Tdap vaccine. The Iowa model was used to guide 
this project as this theoretical framework uses a step by step approach to EBP. The sample 
consisted of one group of 32 pregnant women who receive care at a community based and 
certified midwife led clinic in urban north Indianapolis. The intervention consists of providing in-
person education regarding vaccination importance during pregnancy in the office, followed by a 
series of either text messages or phone calls (participant preference) over the course of the 
study period. Outcomes will be measured by assessing the number of participants who received 
their vaccine(s). Outcomes will be verified using the medical chart to ensure that vaccine(s) 
have been documented as either given or not given. Secondary outcomes will measure the 
percentage of participants who contracted either influenza or pertussis during her pregnancy. 
Demographic data was collected prior to the intervention and recorded. This data will be 
analyzed using a chi-square test to assess the effectiveness of patient education coupled with 
reminder/recall techniques on vaccination uptake in the pregnant population.   
 





Infectious diseases, some even once deemed nearly eradicated, are beginning to pose 
challenges to health care providers (HCPs) as vaccination rates decline (Colgrove, 2016). What 
is known to many as, “anti-vax” or “anti-vaccine” culture, is beginning to yield devastating effects 
while herd-immunity is inevitably diminishing (Colgrove, 2016). This means that if vaccination 
rates continue to decline, recurrence of many infectious diseases could begin to resurface and 
wreak havoc on communities, especially those with vulnerable populations.  
Vaccination uptake has been a rather controversial topic in the field of medicine, nursing, 
and public health due to the increasing popularity to go without or adjust the immunization 
schedule (Colgrove, 2016). Regardless of which option is chosen, the fact remains that being 
non-compliant with the current vaccination recommendations puts individuals at risk, and further 
reduces herd-immunity. While vaccinations given during pregnancy should be considered with 
great care, two commonly indicated vaccinations during pregnancy, influenza and Tdap have 
been shown over time to be safe for pregnant women and overall provide more benefit than 
harm (American College of Obstetricians and Gynecologists, 2017).  Furthermore, the topic of 
vaccination in pregnancy is one that is of great importance and significance when it comes to 
maternal safety and preventing both maternal and fetal complications.   
Pregnant women are considered one of the highest priority groups in  risk of infectious 
diseases and represent a vulnerable population (McMillan et al., 2014). Pre-existing immunity 
exists for pregnant women from a prior contraction of  influenza and/or  pertussis, prior 
immunization against these diseases or both. However, the concentration of antibodies in 
pregnant women is often not sufficient enough to provide passive immunity to the fetus (Raya, 
2017).  
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Furthermore, the effects of a pertussis infection can be extremely detrimental with nearly 
all fatalities of the disease occurring in infants younger than three months of age in the United 
States  and statistically make up for 88% of reported pertussis deaths (Raya, 2017). Thus, 
infants younger than one year of age have the highest per-population incidence of pertussis 
(Raya, 2017). Unfortunately, 75-85% of  pertussis cases in infants are spread from close 
contacts or family members with mothers being the culprit of transmission more than 50% of the 
time (Jones et al., 2016).  
Since influenza is often associated with fever, contraction of influenza by a pregnant 
mother could pose risks such as neural tube defects in the fetus (Centers for Disease Control , 
2020). Additionally pregnant mothers may also experience seizures, difficulty breathing, 
persistent dizziness, lethargy, and overall decreased fetal movements while battling influenza 
infections. All of these factors not only increase the chances of influenza related pneumonia, but 
also hospitalization (Centers for Disease Control, 2020). Furthermore, influenza contraction 
during pregnancy has been linked to premature labor, as well as preterm birth (March of Dimes , 
2021). Thus, it is very important that pregnant women regularly receive their annual influenza 
vaccinations.   
With more individuals, including pregnant women, straying away from standard 
vaccination schedules and recommendations, the importance of patient-provider relationships 
becomes even more vital in combating this major health issue (Colgrove, 2016) and striving 
towards the U.S. Health and Human Services’ Healthy People 2020 goal to vaccinate at least 
80% of pregnant women against the flu (American College of Obstetricians and Gynecologists, 
2018). Since pregnant women are one of the most vulnerable populations to infectious diseases 
and outbreaks, the need for mechanisms to better promote and increase vaccination uptake 
among these women is evident. Vaccination for both influenza and pertussis will not only protect 
women, but their fetuses as well. All in all, vaccination for these two diseases in pregnancy 
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helps to provide better maternal and fetal outcomes and works to prevent the rise of immune-
mediated complications stemming from an infection.   
Data from the Literature Supporting Need for the Project 
During influenza seasons 2010-2011 and 2017-2018, pregnant women between the 
ages of 18-44 years accounted for 24-34% of reported influenza-related hospitalizations in the 
U.S.  Despite public health recommendations, vaccination rates during pregnancy have been 
historically low, with only 52.2% of pregnant women reporting receiving the influenza 
vaccination within the 2013-2014 influenza season (Jones et al., 2016). This percentage has 
since decreased, with only 35.6% of pregnant women reporting receiving the influenza vaccine 
during the 2017 influenza season (CDC, 2017b). Comparing both flu seasons, the rate for 
vaccination uptake has dropped dramatically in the last few years, further indicating a need for 
practice change.  
Compared to the non-pregnant general population of individuals who were eligible to 
receive the influenza vaccine in the 2018-2019 influenza season, only 47.9% of eligible persons 
in the state of Indiana actually received the vaccine (CDC, 2019a). For the influenza season of 
2018-2019, only 33% of individuals aged 18-49 received the influenza vaccine in the state of 
Indiana. For individuals under the age of 18 years old, only 45.3% of individuals were 
immunized (CDC, 2019b). These statistics not only show the relatively low rate of compliance 
for the influenza vaccine in the general population in Indiana but further support the need to 
implement evidence-based interventions to help combat this issue in pregnant women. With 
more individuals opting out of the seasonal flu vaccine, the greater the chance of pregnant 
women contracting the illness becomes, thus presenting a major health risk to pregnant women.  
Tdap vaccination rates, on the other hand, have increased since the year of 2016 with a 
rate increase from 48.8% to 50.4% (CDC, 2018) in pregnant women. However , only 34.8% of 
pregnant women report receiving both vaccines before or during their pregnancies (Lindley et 
al., 2019). As for health care providers, the influenza vaccine was offered or recommended to 
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pregnant women in 73.3% of instances, where the Tdap vaccine was recommended 76.0% of 
the time (Lindley et al., 2019). Of pregnant women who were offered influenza vaccination, 
65.7% of them went on to receive the vaccine. Similarly, 70.5% of women who were offered the 
Tdap immunization received the vaccine during pregnancy (Lindley et al., 2019). This further 
supports the idea that healthcare providers play a vital role in the prevention of communicable 
disease in this population. Thus, healthcare providers must be diligent in performing evidence-
based interventions to address vaccine uptake and be available for questions or additional 
information that patients may need.  
Data from the Clinical Agency Supporting Need for the Project 
Community Health Network, a well-established health care entity throughout the state of 
Indiana is a well-rounded network that has been ranked among the nation’s most integrated 
healthcare systems (“About Community Health Network”, 2019). Community Physician Network 
Women's Midwifery Clinic North is a multi-faceted clinic that provides both women’s care and 
maternal services by women’s health nurse practitioners (WHNP) and certified nurse-midwives 
(CNM). Thus, vaccination uptake is a constant priority for providers practicing at this clinic with 
the goal of sustaining positive fetal/maternal outcomes and healthy pregnancies in general. Like 
many practice settings, this clinic struggles with finding effective strategies for promoting 
vaccination uptake in the maternal population.   
The area which the clinic serves consists of a multitude of cultures, races, ethnic 
backgrounds, and economic backgrounds (Data.census.gov, 2021). Thus, providers at the clinic 
often struggle with finding effective methods to promote vaccination during pregnancy in such a 
broad and ever-changing population. The current practice at the clinic involves patient education 
via hand-outs published by the Centers of Disease Control. Hard copy educational hand-outs 
are given out after the initial verbal offer at the clinic. Up until project implementation, this 
process was the extent to which vaccines were promoted. Using this method offered little to no 
follow-up, opportunity for feedback,  or questions from the patient. Ultimately, a practice change 
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related to vaccination is something that has been identified as a major priority in the pregnant 
population at this facility thus, diverse and evidence-based practice changes were welcomed by 
key stakeholders at the facility (L. Kendrick, personal communication, May 18, 2020). 
When speaking with a nurse midwife at the clinic, it was explained that many pregnant 
women often have good intentions when it comes to getting educated about vaccines. This 
demonstrates  that the population of women that are served are genuinely concerned with the 
health and safety of both themselves and their fetuses. However, patients are often overcome 
with anxiety at the thought of possible vaccination-related reactions or complications. Many of 
the concerns that have been shared regarding vaccines are related to fear of contracting the 
illness in which the individual is being vaccinated against, fear regarding  the safety profile of 
ingredients contained in vaccines, worry about how the vaccine will affect their future health, 
and fear of the vaccine causing birth defects or mental retardation in fetus. (L. Kendrick, 
personal communication, April 16, 2020). With increased access to information and 
contradicting messages regarding vaccine safety and efficacy at the tips of one’s fingers, 
promoting vaccination importance poses a difficult task for CNMs and other health care 
providers (HCP) alike in the clinic. 
Purpose of the Evidence-Based Practice Project 
Evidence-based practice (EBP) is the conscious act of using current and available 
evidence to guide practice and decision making in the clinical setting (Melnyk & Fineout-
Overholt, 2019). The process begins with a systematic search to locate the best and most 
relevant external evidence for critical appraisal. Next, the clinician should use his or her clinical 
knowledge and expertise along with internal evidence generated from outcomes management, 
patient-assessments, or evidence-based quality improvement projects. Most importantly, 
evidence-based practice integrates patient preferences/values into every clinical scenario 
(Melnyk & Fineout-Overholt, 2019). The purpose of this EBP project is to evaluate how 
implementing reminder/recall interventions affects  the uptake of both influenza and/or Tdap 
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vaccination in pregnant women. Vaccination uptake of either of these two indicated vaccines 
during the study period is the primary outcome of this project.  
PICOT Question 
 Unlike research, evidence-based practice poses questions slightly differently. Instead of 
a true research question, many clinicians use the standard PICOT model. This acronym is used 
to describe the population, intervention of interest, comparison of interest, outcome of interest, 
and time of the intervention, or project (Schmidt & Brown, 2019). Specifically, this project will 
address the following PICOT question:  In pregnant women, how do reminder/recall 
interventions and patient-directed education compared to standard practice affect vaccination 
uptake rates within 12 weeks? 
Significance of the EBP Project 
 The focus of this doctorate of nursing practice (DNP) project is extremely significant and 
important in preventing negative outcomes due to preventable infections, in particular influenza 
and pertussis, in pregnant women. The overarching goal of increasing vaccination uptake in 
pregnant women is to ultimately reduce the number of cases of maternal influenza and 
pertussis. Vaccine-preventable diseases such as influenza and pertussis can leave devastating 
effects on pregnant women, and even their fetuses, as mentioned prior. Infants under the age of 
one who contract pertussis are more likely to be hospitalized and are at risk for serious 
complications such as pneumonia, convulsions, apnea, encephalopathy, or even death (CDC, 
2017a). Furthermore, pregnant women who contract the flu are also more likely to be 
hospitalized than non-pregnant women and suffer complications such as pneumonia, premature 
labor, and even premature birth (March of Dimes, 2020). Additionally, febrility from the flu can 
even cause devastating birth defects such as neural tube defects, or spina bifida (March of 
Dimes, 2020). Thus, this project is extremely important to the livelihood and safety of pregnant 
women and infants worldwide. If simple evidence-based interventions such as reminders/recalls 
can be implemented with relative ease into a variety of clinical settings to help to increase 
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vaccination rates among pregnant women, a great chance exists that many lives will not only be 
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CHAPTER 2 
EBP MODEL AND REVIEW OF LITERATURE 
Evidence-based Practice Model 
According to Ingersoll (2000), evidence based practice is “the conscientious, explicit, 
and judicious use of theory-derived, research-based information in making decisions about care 
delivery to individuals or groups of patients and in consideration of individual needs and 
preferences” (p.152). Thus, the three primary components of EBP are research-based 
information, clinical expertise, and patient preferences. This chapter will review the model used 
throughout this DNP project, the literature review conducted, evidence of literature appraisal, 
and an overview and synthesis of the included pieces of literature along with identification best 
practice strategies.  
Overview of EBP Model 
The evidence-based practice model that guides this DNP project is the Iowa model. The 
Iowa model helps to provide nurses and other healthcare providers to make decisions regarding 
clinical and administrative practices that can positively or negatively affect outcomes (Melnyk & 
Fineout-Overholt, 2019). The Iowa model incorporates continuous feedback loops and its 
overall design is widely recognized for its applicability and ease of use by clinicians (Melnyk & 
Fineout-Overholt, 2019). This model was selected for its ability to help interdisciplinary health 
care professionals to translate research into practice and produce real and sustainable health 
outcomes.   
         Step 1:  State the Question or Purpose. The first step of the Iowa model instructs 
clinicians to inquire about practice change opportunities to determine a clinical facility's specific 
needs. This includes identifying triggers, or opportunities for improvement. The next step within 
the Iowa model involves stating the purpose or PICOT question. Having a clear focus and 
objective for an evidence-based practice project helps to clarify boundaries among key 
stakeholders. 
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         Step 2:  Selecting a Topic Priority. Next, the Iowa model encourages the clinician to 
pinpoint the organization’s top priority for practice change and hone in on resources that will 
facilitate an evidence-based practice improvement (Melnyk & Fineout-Overholt, 2019). For 
instance, a clinician may consider prioritizing issues that pertain to “patient safety; high-volume, 
high-risk, or high-cost topics; those that are closely aligned with the institution’s strategic plan; 
or those that are driven by other institutional or market forces (e.g., changing reimbursement)” 
(Melnyk & Fineout-Overholt, 2019, p. 439). 
         Step 3:  Form a Team. After prioritizing the clinical need, the Iowa model recommends 
forming a team. An evidence-based practice team is composed of key stakeholders such as 
nurses, managers, advanced practice registered nurses (APRN), interprofessional colleagues, 
representatives of shared governance committees, and organizational or community leaders 
(Melnyk & Fineout-Overholt, 2019). 
         Step 4:  Assemble, Appraise, and Synthesize Body of Evidence. The next step 
within the Iowa model includes assembling, appraising, and synthesizing evidence. This 
process involves selecting, critiquing, reviewing, and synthesizing all available evidence (Melnyk 
& Fineout-Overholt, 2019). This step may be improved with the aid of a nursing librarian, as 
their skill and knowledge involving online databases and other resources strengthen the 
specificity and relevance of the literature search (Melnyk & Fineout-Overholt, 2019). 
         Step 5:  Obtaining Sufficient Evidence. After appraising the evidence, the Iowa model 
calls for the clinician to determine whether or not there is sufficient evidence. This means that 
the clinician must consider whether the evidence selected is of high quality, and if it is not, 
considering whether to include related evidence or evidence or lower quality (Melnyk & Fineout-
Overholt, 2019). 
         Step 6:  Design and Pilot the Practice Change. According to the Iowa model, the next 
step includes designing and piloting a practice change. Piloting the change helps to keep 
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patients/participants in the loop and further helps to identify potential issues or barriers before 
rolling out the intervention in full form 9 Melnyk & Fineout-Overholt, 2019). 
         Step 7:  Decide if the Change is Appropriate for Practice. After the information has 
been collected from the pilot phase, it is important for the clinician to next decide if the change is 
appropriate for practice. The pilot phase will allow the clinician to determine if revisions or 
modifications need to be made (Melnyk & Fineout-Overholt, 2019). If practice change is deemed 
inappropriate, the clinician can consider redesigning the practice change, waiting for new 
knowledge to develop, collaborating with other experts or researchers in the area, or conducting 
research to guide practice decisions (Melnyk & Fineout-Overholt, 2019). However, if the pilot 
phase showed positive results, the clinician is to continue with the formal roll-out of the practice 
change (Melnyk & Fineout-Overholt, 2019). 
         Step 8:  Integrate and Sustain the Practice Change. The last step of the Iowa model 
includes actually integrating and sustaining the practice change. This is done with the aid of key 
stakeholders. To help sustain the practice change, the clinician will need local champions, 
opinion leaders, and senior leadership support to promote the practice change (Melnyk & 
Fineout-Overholt, 2019). After the practice change has been implemented, continuous 
monitoring and evaluation of the change should occur. The goal of this step is to integrate the 
change into daily practice so that it becomes a part of the facility’s standard of practice. 
Application of EBP Model to DNP Project 
 Step 1:  State the Question or Purpose. The initial step taken following implementation 
of this model in the policy change consisted of stating a purpose for the desired practice change 
at the women’s clinic. This potential area of change was later confirmed to be relevant and 
warranted at this facility by one of the on-site CNMs, who is also the clinical site facilitator. 
According to the site facilitator key elements of the clinical problem surrounding vaccination 
uptake include fear of adverse effects, cost, and disbelief in the need for vaccination. Other 
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pertinent data regarding project  interventions, and potential primary/secondary outcomes were 
identified and discussed with facility staff.   
         Step 2:  Topic Priority. Next, the clinical site facilitator was queried regarding clinical 
priorities and specific areas of need within the facility. After discussion, it was found that there is 
a need for more effective strategies to help promote maternal vaccination uptake. There is a 
great fear among the clinical population surrounding the adverse effects of vaccination during 
pregnancy and thus serves as a major barrier to becoming immunized in this patient population  
(L. Kendrick, personal communication, 2020). Vaccination uptake was deemed the number one 
priority for this clinical facility during the projected study period by facility staff. Furthermore, 
vaccination of pregnant women was also considered a top priority due to the current global 
pandemic involving COVID-19 and the possible heightened risks of respiratory infections during 
this time (Terreri, 2020). Since the COVID-19 pandemic, there was a much greater sense of 
overall panic and fear within the clinic from patients. Patients' concerns for contracting serious 
respiratory illnesses was obviously heightened, and thus the desire to complete influenza 
vaccination was seen as dramatic compared to previous years, according to clinic staff.  
         Step 3:  Form a Team. After the priority issue was presented to both the CNM and other 
clinic staff at the facility, there was a consensus that there is a clinical indication for 
implementing evidence-based practice within the facility and a team to help implement a 
practice change was formed. The team consists of the clinical site facilitator, three other CNM 
providers in the clinic, and the clinic supervisor. Members of the team were briefed on the 
preliminary details of the intervention for practice change and consulted regarding their 
knowledge and experience with the topic of vaccinations in this population. 
         Step 4:  Assemble, Appraise, and Synthesize Body of Evidence. Evidence was 
carefully searched using online scholarly databases, evidence was selected using stringent 
inclusion and exclusion criteria, limited for relevancy, and evaluated/critiqued for quality. 
Assistance from a library professional was sought, and feedback regarding search techniques 
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was given. After following professional recommendations from the nursing librarian, the selected 
literature was reviewed and shared with key stakeholders at the clinical site. 
         Step 5:  Obtaining Sufficient Evidence. Sufficient and high-quality evidence was found 
within the literature by using a multitude of scholarly databases. It was purposeful that different 
types of evidence were included in the final review of literature, as to fully encompass the great 
span of knowledge that has already been explored surrounding the topic of vaccination. 
         Step 6:  Design and Pilot the Practice Change. Next, a plan was designed to pilot the 
practice change. During the pilot phase, I discovered both resources and barriers that could 
impact the effectiveness of the final intervention. Resources included on-site computer access 
and wifi. Barriers found during this phase include lack of overall staff compared to patient load, 
limited time for additional activities during the clinical workflow, and hesitancy of patients to sign 
up for automated messages or phone calls. A draft of the practice protocol was given to all 
involved providers and clinic staff, keeping in mind the clinic flow and complexity. Research 
measures were simplified to reflect the process and focus of the evidence-based practice 
project.  
         Step 7:  Decide if the Change is Appropriate for Practice. After more information was 
collected from the pilot phase, a decision was made regarding the appropriateness of the 
project in the clinical setting. Modifications and adjustments were made to the design of the 
project based on provider/patient feedback. For example, instead of only stating that the patient 
would receive automated text-messages or phone calls without stating at what frequency, clinic 
staff agreed that using the phrase “weekly reminders” produced better outcomes and made 
patients more willing to sign up for reminders, as it is believed that patients were more 
comfortable knowing that they would only be contacted weekly, instead of daily, or every other 
day, for instance. Additionally, it was found that information entry into the digital platform was 
easier and less confusing when one person was appointed to perform the task, as compared to 
multiple individuals. 
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         Step 8:  Integrate and Sustain the Practice Change. After entry of data into the digital 
platform was complete, continuous monitoring of the medical chart was performed by all nursing 
personnel such as the MAs and RNs. A new job role was created to reflect the new 
responsibilities of the staff. Reminders posters stating “Remember to perform maternal 
vaccination education at the end of all prenatal visits, as well as collect contact information for 
vaccine reminders!” were set in high traffic areas to remind all staff of the new clinic procedures 
and to help further solidify this practice change in the everyday clinical flow. Additional time was 
incorporated into patient appointment times in order to account for the amount of time in-person 
vaccination education using hand-outs, as well as time for the collection of phone numbers for 
automated reminders. 
Strengths and Limitations of EBP Model for DNP Project 
        The Iowa evidence-based practice model is an ideal model for students and clinicians to 
use when conducting evidence-based practice due to its detailed and concise steps. The nature 
of this model allows the project leader to continuously receive feedback, and thus make 
adjustments to the intervention in order to best suit the clinical environment. More so, this model 
includes a pilot step that serves great benefit to the clinician in that it allows for a mock trial of 
the intervention to highlight and address potential flaws or adjustments that need to be made. 
Additionally, this model encourages a collaborative and team approach to research, which is 
especially relevant to the very nature of evidence-based practice in the nursing discipline. 
        A limitation of this model is that it does not facilitate evidence-based practice for 
individual clinicians. Since this model encourages a team-based approach, implementation of 
interventions was difficult at times due to all key stakeholders not always being on the same 
page for the practice change. Additionally, this model required a pilot phase to take place before 
the formal implementation of the intervention. This phase was a barrier as clinicians were 
already working in a facility with time-constraints as far as appointment scheduling and limited 
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resources/staff. The pilot phase took additional time, thus, this extra step seemed to be 
somewhat time burdening on the staff.  
Literature Search 
Sources Examined for Relevant Evidence 
Sources examined for this DNP project were drawn from five scholarly databases 
including the Joanna Briggs Institute (JBI), the Cochrane Library, the Turning Research into 
Practice (TRIP) database, the Cumulative Index of Nursing and Allied Health Literature 
(CINAHL) database, and MEDLINE (See Table 1.1 ). Within JBI, search terms included vaccin* 
OR immuniz* OR immunis* OR inoculat*AND uptake OR improv* OR promot* OR attain* limited 
by publication date of 2015 or beyond. This search strategy yielded 138 results, in which two 
pieces of literature were selected for inclusion. Articles excluded from selection included articles 
that mentioned vaccination or immunization but did not list any interventions for increasing 
uptake. The next database that was searched was the Cochrane Library. Search terms in this 
database included vaccin* OR immuniz* OR immunis* OR inoculat* AND increas* OR promot* 
OR uptake OR attain* OR improv*. This strategy yielded 62 results in which three articles were 
selected. This search was limited by the publication year 2015 and later. Articles that were 
focused on pediatric populations only, or listed no intervention were eliminated. Next, the TRIP 
database was searched using a title search for the keyword: vaccine OR immunization OR 
immunisation, AND (uptake OR improv*). The search was limited to a publication date of 2015 
and beyond. Further limitations included systematic reviews, evidence-based synopses, and 
clinical guidelines. Of the 145 results, four articles were selected. Articles that pertain only to 
neonatal patients, or interventions aimed at reducing pain during vaccinations were excluded. 
The CINAHL database was searched next utilizing the major subject heading and key terms:  
(MM "Immunization") AND uptake OR improv* OR promot* OR attain* AND intervent*. This 
search was also limited to the publication date of 2015 or later. Articles were only selected if 
they were scholarly, peer-reviewed journals in the English language, or research articles. Three 
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out of 286 articles were selected for inclusion. Articles that focused on only neonatal 
populations, or only provider-based interventions were excluded. Lastly, the MEDLINE database 
was searched using the following heading and key terms:  (MM "Vaccination+") AND uptak* OR 
intervent*. This search was limited to the publication year of 2015 and later. Only scholarly or 
peer-reviewed articles, journals, or articles in the English language were included. No articles 
were selected for inclusion from this database. 
Table 1.1 
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Levels of Evidence 
 The evidence reviewed within this DNP project was reviewed and leveled using the 
Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool. This tool 
is divided into two separate tools that evaluate both research and non-research evidence. The 
research appraisal tool identifies level I evidence as studies that involve manipulation of an 
independent variable, a control group, and random assignment to intervention and control 
groups, thus including randomized-control type of studies (RCT) and  systematic reviews 
containing all RCTs. Level II evidence was identified as evidence that involved the manipulation 
of an independent variable and the presence of a control group, but no randomization of groups, 
or only manipulation of an independent variable. This type of study is thus identified as quasi-
experimental. Additionally, level II evidence includes systematic reviews containing a 
combination of RCTs and quasi-experimental, or quasi-experimental only. Level III evidence is 
recognized as evidence that does not involve any of the three previously listed criteria and thus 
is categorized as non-experimental. This also includes systematic reviews that contain a 
combination of RCTs, quasi-experimental, and nonexperimental, or nonexperimental only 
evidence. This type of data is often either descriptive, comparative, correlational, or secondary 
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data. The non-research portion of this appraisal tool recognizes both clinical practice guidelines 
and consensus or position statements as level IV evidence. Clinical practice guidelines are 
defined as systematically developed recommendations that are composed of known experts in 
the field and based on research evidence. Consensus or position statements are defined as 
systematically developed recommendations that are based on the opinions of recognized 
experts that lead professional organizations of specific disciplines. Literature reviews and 
integrative reviews are classified as level V evidence according to the Johns Hopkins appraisal 
tool. Literature reviews are recognized as summaries of publicly available literature, while 
integrative reviews consist of summaries of research evidence and theoretical data. Also 
included in level V evidence are quality improvement data, financial evaluations, program 
evaluations, case-reports, and community standards, clinician experience, or consumer 
preference literature. 
         Using the Johns Hopkins Nursing Evidence-Based Practice Research Evidence 
Appraisal Tool, two pieces of evidence fall into the category of level I, six pieces are level II, and 
four pieces are level IV (See Table 1.2).  
Appraisal of Relevant Evidence 
Quality appraisal was done using the same tool used for rating the levels of the 
evidence, the Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal 
Tool. For the research evidence section of this tool, quantitative evidence is rated as high 
quality if it offers consistent and generalizable data. High-quality data also utilized adequate 
sample size, sufficient control, and definitive conclusions. High-quality literature (Grade A) 
incorporates a thorough and nearly exhaustive literature review process that references 
scientific data. Good quality literature (Grade B) is detailed as data that presents reasonably 
consistent results, some degree of control, adequate sample size, and fairly definitive 
conclusions. The literature review for good quality data is usually only fairly comprehensive, in 
contrast to high-quality data. Low-quality literature (Grade C) is literature that provides 
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inconsistent results, with an inadequate sample size. Conclusions are not able to be accurately 
drawn from low-quality data.  
Figure 1.1 
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 In regards to the non-research evidence appraisal tool, clinical practice guidelines, and 
consensus, or positions statements, are rated as either high, good, or low quality evidence. 
High-quality data is usually sponsored by a public or private professional agency or organization 
and includes evidence of a systematic literature search strategy. Results will be consistent and 
include an adequate amount of well-designed studies. Furthermore, high-quality data must also 
be published within the last five years. Good quality evidence is literature that is sponsored by 
an organization or government agency. The literature search is fairly exhaustive and 
appropriate. The results in good quality evidence are only fairly consistent and are published 
within the last five years. Lastly, low-quality evidence is evidence that is not officially sponsored 
by a professional, public, or private institution and does not provide a well-defined or complete 
literature search strategy. Additionally, there is no overview of strengths and limitations, and no 
reasonably consistent results or data are evident.    
Level I Evidence 
Cutrona et al. (2018). This randomized controlled trial evaluated the effect of patient 
reminders delivered via an electronic health record (EHR) patient portal and interactive voice 
response (IVR) calls on the uptake of influenza vaccinations in adults who have no documented 
receipt of an influenza vaccine after two months into the annual influenza season to evaluate 
the effectiveness of this intervention on increasing vaccination uptake rates. This randomized 
controlled trial included 20,000 patients that were split into intervention groups. Within these 
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groups, participants were to receive either (a) receipt of a portal message promoting influenza 
vaccines, (b) receipt of an IVR call with similar content, (c) both A and B, or (d) only usual care. 
No specific description of usual care was noted. Participants were selected for inclusion into the 
study if they actively visited a medical group primary care provider (PCP) and were at least 18 
years of age. Participants who had a documented influenza vaccine allergy in the EHR, or who 
requested to be on the do-not-call list were excluded. Secure reminder messages sent via the 
patient portal were in letter form and signed by each patient’s individual primary care provider. 
An email was sent containing a link to complete an influenza questionnaire. Also contained 
within the portal reminder was information from the CDC on vaccinations. IVR intervention 
strategies consisted of automated phone calls using voice recognition technology to elicit patient 
self-report of influenza vaccination uptake at an outside facility or source. If patients reported no 
uptake of the influenza vaccination, the automated service then asked the patient about what 
barriers were present and responded with concise and targeted health education. Out of the 
four intervention groups, 14.0% (702) received both portal messages and calls, 13.4% (669) 
received only portal reminders, 12.8% (642) received only call reminders, and 11.6% (582) 
received usual, or standard care. Using a multivariate analysis, those receiving portal reminders 
alone or IVR calls alone were more likely than usual care recipients to be vaccinated (OR 1.15 
95% CI 1.02–1.30). Those receiving portal reminders and IVR calls were also more likely than 
the usual care group to be vaccinated (OR 1.29, 97.5% CI 1.13, 1.48). Among non-portal users, 
8.5% of call recipients and 8.6% of usual care recipients received influenza vaccines. Thus, the 
authors concluded that both patient portal reminders and IVR calls proved to be clinically and 
statistically significant, and useful for implementation into clinical practice for improving influenza 
vaccination rates in adult patients. This RCT was rated as high quality, or grade A using the 
Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool. 
James (2018). A JBI evidence summary looking into the best available data regarding 
interventions to increase and sustain child immunization status reviewed over 22 high-quality 
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scholarly sources. The purpose of this evidence summary was to review evidence-based 
interventions that have been shown to produce a significant difference in vaccination uptake. 
The studies under review were conducted worldwide including in the USA, Zimbabwe, Mexico, 
Nicaragua, Nepal, Pakistan, India, Ghana, Uttar Prades, Kenya, South America, South East 
Asia, Central/South America, and Mali. Interventions such as conducting home visits, re-
organizing clinic procedures to shorten wait times, vaccinating patients who present to the office 
for unrelated reasons, reminders/recall strategies, door to door canvassing, mass media 
campaigns and health education were analyzed and reviewed and recommended as effective 
strategies for increasing vaccination uptake (Grade B). Reminder interventions such as 
vaccination reminder cards given to patients in the office and verbal in-office reminders were 
recommended in several studies within this evidence summary. Such reminder strategies have 
been shown to be effective, yet cost efficient for health care facilities, thus further supporting the 
use of these simple measures. The overall quality assessment of this evidence summary is 
rated as good quality, as this review included a thorough literature search with fairly consistent 
results. 
         Moola (2018). Sandeep Moola published a good quality (Grade B) JBI evidence 
summary in 2018 detailing the effectiveness of reminder/recall intervention in the uptake of 
vaccines in the general population. This evidence summary analyzed the best available 
evidence regarding patient reminder and recall interventions for improving vaccination status. 
This evidence summary analyzed a level I systematic review published in 2018, which included 
75 studies. Specific reminder/recall interventions under review included:  person-to-person 
telephone calls, mailed letters, postcards, text messages, and autodialed calls. Combinations 
include either:  letters or postcards plus telephone or autodialer calls, and provider reminders, 
coupled with a patient reminder or recall interventions. Telephone reminder or recall 
interventions were shown to increase receipt of vaccines as well (RR 1.75; 95% CI 1.20 to 
2.54). Individuals who received letters or physically mailed reminders were 1.29 more times 
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likely to receive vaccination than those who did not receive those reminders (95% CI 1.21 to 
1.38). Those who received postcard recalls were also more likely to become vaccinated than 
those individuals who did not receive postcard recalls (RR 1.18; 95% CI 1.08 to 1.30). Text 
message reminders significantly proved more efficacy in improving vaccination uptake 
compared to standard practice and those within the control group (RR 1.29; 95% CI 1.15 to 
1.44). Autodialer reminder interventions were also shown to induce improvements in immunity 
compared to standard of practice (RR 1.17; 95% CI 1.03 to 1.32). Overall, this evidence 
summary indicates that patient-focused reminder/recall interventions, specifically telephone 
calls and mailed letter reminders  are more effective at increasing vaccination rates than 
provider focused interventions (RR 1.28; 95% CI 1.23 to 1.35). Furthermore, combining multiple 
interventions also provided some confirmation of efficacy, as participants who received both 
mail and telephone reminder or recall combination interventions were 1.28 times more likely to 
receive immunizations than those who did not (95% CI 1.14 to 1.45). Participants who received 
patient reminder or recall interventions in combination with provider outreach were more likely to 
receive immunizations than those who did not  (RR 1.22; 95% CI 1.10 to 1.35). Lastly, 
participants who received a combination of patient reminder or recall interventions and provider 
reminder interventions were more likely to receive immunizations than the control group 
participants (RR 2.91; 95% CI 2.67 to 3.19). Ultimately, the author of this evidence summary 
concluded that patient-focused reminder/recall interventions should be implemented to help 
increase vaccination uptake. Furthermore, this author suggests the implementation of different 
types of reminders/recalls that best suit individual clinical environments and practice needs.  
Region of Peel (2019).  A rapid review conducted by the Region of Peel public health and 
communicable diseases division analyzed the literature to evaluate what interventions impact 
HPV vaccine uptake among adolescents. Three systematic reviews were selected for inclusion. 
Studies chosen for inclusion were in the English language and had a publication date of 2007 
and onward. The literature search was also limited to only include synthesized literature or 
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guidelines. Studies that focused on HPV effectiveness/efficacy that took place in developing 
countries or focused on cost/benefits were excluded from this review. Synthesis of the literature 
showed that HPV vaccination uptake is somewhat increased with the implementation of school 
or class-based vaccination. Two of the included studies concluded that HPV vaccine uptake 
among females aged 10-17 years who were offered the vaccine at school-based clinics was 
increased compared to control groups (OR 6.56, 95% CI 3.99 to 10.78). Another study included 
in this review revealed that school-based vaccination increased the uptake of at least one HPV 
dose significantly more among females in the sixth grade (RR 1.69, 95% CI 1.21 to 2.36) and 
seventh grade (RR 2.56, 95% CI 1.34 to 4.88) compared to controls. In seven of the studies, 
reminder/recall interventions significantly increased vaccination uptake. Interventions included 
mailed letters, telephone calls, home visits, scripted provider interactions, and a combination of 
web-based reminders with educational brochures. Of the included studies, reminder/recall 
interventions produced variable effects, as different increases in uptake rates were with each 
dose of the HPV vaccine. In one study, the initial HPV dose uptake did not increase (RR 1.1, 
95% CI 1.0 to 1.2), but uptake of the second (RR 1.2, 95% CI 1.1 to 1.3) and third doses (RR 
1.4, 95% CI 1.2 to 1.5) were significantly improved among participants who received automated 
telephone calls compared to those who did not receive calls. Conversely, in another study 
reminder/recall interventions showed no effect on HPV vaccination uptake among participants 
aged 18-26 years old. These individuals received preference-based reminders in the form of 
telephone calls, mailed letters, text messages, e-mails, and/or private Facebook messages. In 
three of the studies, provider interventions included a “1:1 scripted provider intervention and a 
web-based reminder system to prompt telephone calls paired with an educational brochure for 
parents”, a webinar by the CDC coupled with weekly follow up emails, and a provider tip sheet 
with online training combined with posters, brochures, radio public service announcements and 
a website (p. 17). These interventions were also shown to be statistically significant in 
increasing HPV vaccination uptake among females aged 11-12 years by 4.9% using in-person 
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interventions, and 5.3% using web-based strategies (p˂0.05). Due to the presence of an 
adequate literature search strategy and relatively consistent results, this review was rated as 
good quality, (Grade B).  
Level II Evidence 
Abdullahi et al. (2017). This systematic review includes a thorough literature search of 
11 scholarly databases as well as two clinical trial platforms, electronic databases of grey 
literature, and reference lists of relevant articles. The inclusion criteria for this systematic review 
includes eight individually randomized trials, four cluster randomized trials, three non-
randomized trials, and one controlled before and after study. For inclusion, articles had to have 
at least two intervention groups and two control groups. Controlled before and after studies also 
required at least two intervention groups and at least two comparable control groups, with 
simultaneous data collection. Data that were excluded from the review included simple pre-post 
designs, cluster-randomized and non-randomized trials with only one intervention or control 
group, and controlled before-after studies without concurrent data collection among both 
intervention and control groups. Additionally, articles that focused on interventions to remind 
providers of immunization services were excluded, as there is already a systematic review 
covering this topic. The studies under review analyzed interventions that were targeted toward a 
wide range of populations including adolescent boys or girls or both (seven), parents (four), and 
providers (two). Five studies used a mixed participant population including adolescents and 
parents, adolescents and healthcare providers, and parents and healthcare providers. 
Outcomes analyzed within this systematic review were:  uptake of human papillomavirus (HPV) 
hepatitis B, tetanus-diphtheria–acellular–pertussis (Tdap), meningococcal, and influenza 
vaccines. According to this review, health education by means of structured interactive 
education sessions on the target disease, vaccine recommendations, vaccine schedule,vaccine 
efficacy, and vaccine safety improved HPV vaccine uptake compared to the standard practice 
(RR 1.43, 95% CI 1.16 to 1.76).  Furthermore, complex multi-component health education 
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resulted in little to no improvement in vaccination uptake for hepatitis B than simplified 
information leaflets, or handouts (RR 0.98, 95% CI 0.97 to 0.99). Complex multi-component 
health education consisted of a resource fact sheet and assessment, an informational video and 
corresponding questions designed to engage the adolescent audience, small group discussions, 
and an activity to locate resource information on the Internet. Another intervention that was 
analyzed within this systematic review was financial incentives. According to the cumulative 
results of the studies reviewed, financial incentives such as shopping vouchers upon 
vaccination completion improved vaccination uptake slightly more than standard of practice (RR 
1.45, 95% CI 1.05 to 1.99). However, when coupled with health education, the efficacy of these 
two interventions is not well established and thus is not statistically significant in the promotion 
of vaccination uptake (RR 1.38, 95% CI 0.96 to 2.00). Mandatory vaccination was found to 
produce significant findings in one study of 6,462 participants (RR 2.94, 95% CI 2.66 to 3.25). 
Studies that compared the utilization of provider reminder prompts to standard of care found 
that reminder prompts made little to no difference in the uptake of Tdap (OR 1.28, 95% CI 0.59 
to 2.80), meningococcal (OR 1.09, 95% CI 0.67 to 1.79), HPV (OR 0.99, 95% CI 0.55 to 1.81), 
and influenza (OR 0.91, 95% CI 0.61 to 1.34) vaccines. Provider education with performance 
feedback was found to be slightly effective in increasing HPV vaccination uptake in participants 
with a 5.7% increase in initial dose uptake for participants seeing providers that performed 
vaccination education with performance feedback compared to standard practice. Vaccination 
education with performance feedback consisted of providers performing patient education and 
afterwards receiving a medical record generated performance feedback report with each 
provider’s rate of captured HPV vaccination opportunities. Additionally, the educational session 
for providers was a 1-hour webinar that described current vaccination rates in the network, data 
on vaccine safety and efficacy, and strategies for overcoming barriers to vaccination uptake. 
School or class-based vaccination was also shown to increase vaccination uptake (RR 1.09, 
95% CI 1.06 to 1.13). Lastly, multi-component provider interventions that included an education 
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session, repeated contacts, individualized feedback, and incentives significantly improved HPV 
vaccination uptake compared to standard practice (RR 1.41, 95% CI 1.25 to 1.59). The authors 
concluded while many different techniques have been implemented to increase vaccination 
uptake, more research needs to be conducted to further enhance a clear definition of best 
practice for improving immunization status. While this review did include some quasi-
experimental, non-randomized, and non-controlled trials, the literature search strategy was 
appropriate and extensive, including a review of grey literature and citation chasing. However, 
this review is limited as the overall certainty of the results is reduced due to its evidence level. 
Moreover, due to the extensive literature review, consistent results, and inclusion of eight 
randomized-controlled trials, this review was rated as high quality (Grade A). 
 Mazzoni et al. (2016). A quasi-experimental study conducted at two separate clinics 
evaluated the effect of a multimodal intervention on rates of immunization with Tdap, HPV, and 
influenza vaccines in outpatient obstetric/gynecology settings. Strategies that were a part of the 
multimodal intervention included stocking of vaccines in the clinics, modification to standing 
orders, development of a reminder/recall program, identification of an immunization champion, 
expansion of a payment assistance program, and staff education. All women age 15 or older 
who visited the clinic during the influenza season were included in the influenza study cohort. 
Participants who delivered a baby during the study period and had been to at least one prenatal 
check-up during pregnancy were included in the Tdap cohort. Non-pregnant women who 
frequented the clinic during the study period aged 15-26 were enrolled in the HPV cohort. The 
demographic of the study population consisted mainly of Hispanic, English-speaking, and 
publicly insured women. Staff education was administered in the form of 2 separate education 
sessions with one covering HPV, and the other covering Tdap vaccination during pregnancy. 
Existing vaccine standing orders were revitalized and expanded dependent on the specific 
vaccine. For instance, standing orders were optimized to include the influenza vaccine in the 
out-patient setting, as it was previously only auto-ordered for in-house patients within the larger 
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health care system. The deployment of an immunization champion was also utilized within this 
study. Immunization champions were registered nurses who performed periodic chart reviews 
and provided real-time feedback when opportunities for vaccines were missed. Additionally, 
feedback from staff was collected at the mid-way point in the study and used for intervention 
improvement. Furthermore, staff began to order and stock Tdap vaccines in the clinic, as these 
were typically not available for same-day administration pre-implementation. Education hand-
outs were also given to patients at prenatal and ultrasound visits.  Due to the disparity in health 
insurance coverage that persists in the surrounding clinic area, the clinic had a pre-established 
payment assistance program that aided uninsured women to cover the cost of the HPV vaccine 
at one of the clinics. Revitalization of this program included the expansion of the payment 
assistance program to both clinics. Reminder/recall interventions were instituted to notify 
patients when the second and third doses of the vaccine were due. At the initial dose 
administration, patients were queried as to whether they preferred telephone or mail 
communication. After communication preferences were established, the immunization champion 
then contacted each patient up to three times when their next doses were due. Post-
intervention, influenza vaccination uptake increased from 35.4% to 46%. After controlling for 
age, race/ethnicity, and insurance, the authors concluded that participants were more likely to 
receive vaccination post-intervention than they were pre-intervention (P <.001). The overall 
percentage of Tdap uptake increased from 87.6% pre-intervention period to 94.5% post-
intervention period. Compared to the pre-intervention period, overall vaccination rates were 
significantly increased after intervention implementation (z = 4.58, P < .0001). HPV uptake also 
increased, as rates increased from 7.1% before the intervention to 23.7% after the intervention. 
A stratified analysis also revealed that HPV vaccination uptake rates were increased in all 
insurance groups. Those with private insurance saw an increase from 7.8% to 19.3% after 
(P=.0155). Participants who carried public insurance saw an increase in vaccination rates from 
6.5% before to 22.3% after (P < .0001). Lastly, uninsured participants HPV vaccination rates 
EBP PROJECT            44 
 
were significantly improved from 7.6% before to 24.3% after (P<.0001). This article was chosen 
based on its high quality (Grade A) and consistent results. The authors used an adequate 
sample size for the intervention and provided consistent conclusions and recommendations 
based on pre-existing literature and statistical tests used within the study. 
         Posadzki et al. (2016). Posadzki et al. (2016) conducted a systematic review that 
analyzed 132 randomized, cluster- and quasi-randomized trials, and controlled before-and-after 
trials selected from 10 different scholarly databases. The purpose of this systematic review 
serves to explore and synthesize the best available evidence for the role of automated 
telephone communication systems (ATCS) on preventative health care and management of 
long-term conditions. ATCS send voice messages and collect health information from people 
using their telephone's touch-tone keypad or voice recognition software, which could replace or 
supplement telephone contact between health professionals and patients. Articles that targeted 
only health professionals or teachers were excluded. Additionally, articles that offered no health 
promotion or interactive elements, or  involved only a non-ATCS component such as face-to-
face communication or written communication, were also excluded. Primary outcomes 
measured included health behaviors changes? and clinical outcomes. Changes in health 
behavior were defined as physical activity, adherence to medications/uptake of recommended 
laboratory, or other testing/procedures, which includes vaccinations. Of the 132 included 
studies, Forty-one studies evaluated ATCS for delivering preventive healthcare, 84 for 
managing long-term conditions, and seven studies for appointment reminders. In regards to 
preventative health care, ATCS improved vaccination uptake in children by 1.25 times (95% CI 
1.18 to 1.32). While this same intervention was shown to also improve vaccination uptake in 
adolescents, the efficacy in this population is much lower (RR 1.06, 95% CI 1.02 to 1.11). 
Unfortunately, the effects of ATCS in adults remains unclear (RR 2.18, 95% CI 0.53 to 9.02). 
From these results related to vaccination uptake, the author concludes that ATCS interventions 
have the ability to improve patient health behaviors and impact key areas of health such as 
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immunization, screening, appointment attendance, and adherence to medications or tests. Due 
to this review’s systematic and exhaustive literature search and consistent results, this piece of 
evidence was rated as high quality, or grade A. 
 Molokwu et al. (2019). Molokwu et al. conducted a prospective quasi-experimental 
community-based study utilizing a pre-test post-test design. This study was conducted to 
evaluate the effects of culturally tailored EBP interventions on HPV vaccination rates and 
psychosocial factors in a largely Hispanic, low-income population. A total of 1796 participants 
who have no documentation of receipt of the HPV vaccine series were included in the study with 
ages ranging from 9-26 years old. Furthermore, participants had to be underinsured, or 
uninsured, and have a Texas address. A series of interventions performed in this study include 
patient outreach, education, and navigation, and the provision of vaccines to eligible individuals. 
Materials for education sessions were inspired by the Health Belief Model (HBM) and guided by 
findings from a series of other clinical studies. Education materials were provided in both 
English and Spanish languages. Information about cervical cancer, HPV transmission, HPV 
vaccine indications, series schedule, contraindications, and adverse reactions was included in 
the material. Consequently, the education resources also addressed reasons why many 
individuals do decide to vaccinate, thus correlating positive benefits with vaccination. The 
intervention was even performed verbally with accompanying audiovisual aids which have been 
shown to increase knowledge in similar low-income Hispanic communities. Furthermore, 
interventions were delivered by bilingual community health workers to further address any 
potential cultural or language barriers. The navigation portion of the intervention consisted of 
designated staff who functioned to gather community resources, assist with scheduling, 
transportation assistance, and also initiated vaccine tracking and reminders. Reminder phone 
calls were made during the study period at 2, 6, and 12 months. If no contact was made by at 
least the third phone call, navigators sent participants a letter with program contact information, 
and further communication was ceased. Access to vaccination was also impacted as a part of 
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this multi-component intervention, as free HPV vaccines were offered to qualifying participants, 
and administered on-site or scheduled for a later date. Overall, the HPV vaccine initiation and 
vaccine completion rates were 67.1% and 39.8% respectively for both children and adults. 
Within the study, adults showed higher vaccination initiation rates at 77.4% (95% CI 74.6% to 
80.0%) compared to children at 55.8% (95% CI 52.4.6% to 59.1%). Contrastingly, the 
completion rate for the series among adults was only 31.6% (95%CI: 28.6% to 34.7%) 
compared to 48.7% in children (95% CI 45.3% to 52.1%). Overall, greater than half of the study 
population (55.5%) completed two doses of the vaccination series. This level II evidence has 
been categorized as high quality (Grade A) based on its consistent results and manipulation of a 
variety of different independent variables. 
         Vann et al. (2018). A systematic review analyzing 75 randomized trials, controlled 
before and after studies, and interrupted time-series studies evaluated patient reminder or recall 
interventions in children, adolescents, and adults in outpatient, community-based, primary care, 
and other settings. Patient reminder or recall interventions consisted of telephone and autodialer 
calls, letters, postcards, text messages, a combination of mail or telephone, or a combination of 
patient reminders or recall with outreach. Individually implemented interventions such as 
postcards, text messages, and autodialer calls significantly increased vaccination uptake among 
participants in the reviewed studies (RR 1.18, 95% CI 1.08 to 1.30; RR 1.29, 95% CI 1.15 to 
1.44; RR 1.17, 95% CI 1.03 to 1.32) respectively. Telephone calls (RR 1.75, 95% CI 1.20 to 
2.54) and mailed letters (RR 1.75, 95% CI 1.20 to 2.54) also improved vaccination uptake, 
however with a lesser degree of certainty than the previously mentioned interventions. When 
combined, mail and telephone reminder/recall strategies also showed increases in vaccination 
uptake in children, adolescents, and adults (RR 1.28, 95% CI 1.14 to 1.45). The combination of 
patient reminder or recall with provider outreach interventions also resulted in significant results 
for increasing vaccination uptake (RR 1.22, 95% CI 1.10 to 1.35). For adult populations, 
reminder/recall interventions result in a 1.29 increased chance of vaccination uptake (95% CI 
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1.17 to 1.43). Furthermore, the authors concluded that overall, reminder/recall interventions 
improved vaccination uptake in childhood (RR 1.22, 95% CI 1.15 to 1.29) and adolescence (RR 
1.29, 95% CI 1.17 to 1.42). This systematic review was included in this DNP project due to its 
wide array of different reminder/recall interventions tested within the literature, consistent and 
significant results, and extensive literature review search strategy. Thus, this review was rated 
as high quality (Grade A). 
Level IV Evidence 
         American College of Obstetricians and Gynecologists (2019). This clinical practice 
guideline (CPG) was developed by the American College of Obstetricians and Gynecologists’ 
Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group to 
extensively review the best available evidence from the literature and expert opinion regarding 
interventions to increase vaccination uptake among pregnant women. According to the 
committee, OB-GYNs and other providers alike should first begin by providing education to 
patients in an evidence-based manner. Furthermore, after formal education has taken place, the 
provider should then document whether the patient received or refused the vaccine, and discuss 
options and alternatives with patients who decide to decline vaccination at the time of visit while 
making sure to remind and offer the specified vaccine at the next clinic appointment. 
Furthermore, immunization should be delegated among other clinic staff, and an immunization 
champion should be delegated. The immunization champion would then be responsible for 
ordering, receiving, and ensuring vaccines are kept and stored and appropriately, while also 
serving as a vaccine resource for other staff and patients. ACOG also endorses paper or 
electronic reminders for providers, such as those built into electronic medical records (EMRs). 
These types of reminders highlight opportunities when patients are in the office for regularly 
scheduled appointments and can help to catch patients in-person for real-time vaccination 
education and administration. This guideline was rated as high quality (Grade A), as evidence 
was derived from the literature and scientific evidence, and not solely expert opinion. 
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 Australian and New Zealand Society for Geriatric Medicine (2018). This CPG was 
developed to inform and educate about the importance of increasing vaccination uptake in the 
adult population. This guideline reviews considerations and indications gathered from the 
Cochrane Library database for many vaccinations including influenza, tetanus, herpes zoster, 
pertussis, and pneumococcal vaccines. In regards to strategies for increasing vaccination 
uptake, this CPG suggests provider recommendations and education to promote positive 
attitudes towards vaccination. Reminder/recall interventions in the form of telephone calls or 
mailed letters were also referenced from the literature as beneficial methods for improving 
uptake. Furthermore, this guideline also endorses mandated vaccination policy implementation, 
as it states that “institutional policies to offer the vaccine to all residents/patients” should also be 
considered (p. 3). However, it does mention that participants should have the option to refuse. 
Other recommended strategies that have been trialed in the literature consist of:  vaccinating in-
patients upon discharge from the facility, encouraging medical specialists to emphasize and 
individualize vaccination recommendations when communicating with other PCPs, using 
educational forums to emphasize the benefits of and barriers to vaccination, and setting up 
displays in common areas including pharmacies and storefronts. Additionally, this CPG 
recommends implementing on-site vaccination clinics in pharmacies and other similar 
establishments. Due to the lack of an exhaustive literature search strategy, and degree of expert 
opinion, this CPG was rated as good quality (Grade B). 
         The National Institute for Health and Care Excellence (2018). Strategies aimed at 
increasing vaccination uptake in eligible individuals are analyzed and described in great detail 
within this CPG. This guideline was developed for the purpose of bringing about awareness 
surrounding the need for vaccines, and how to use all opportunities in primary and 
secondary care facilities to help identify people who should be encouraged to become 
immunized. Similar to other data found in the literature, this guideline suggests a multi-
component intervention strategy to achieve significant results for vaccination uptake. First, 
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medical staff who are prone to come into close and regular contact with eligible unvaccinated 
individuals should be educated about vaccinations and their safety/efficacy profiles. Regarding 
the influenza vaccine, education surrounding eligibility for the vaccine, benefits of vaccination for 
people at high risk from the flu and its complications, how the flu is transmitted, and how the 
vaccine is administered (either via nasal spray or intramuscular injection). Accordingly, 
providers should inform and offer eligible patients flu vaccination during face-to-face visits, and 
whenever the opportunity arises. Furthermore, when inviting individuals to receive a vaccination, 
medical staff should ensure that invitations and other health information come from a provider 
that the patient knows, and includes a degree of personalization to the patient’s clinical status 
such as in pregnancy or a chronic health condition. More importantly, invitations to vaccinate 
should discuss the potential risks of not being vaccinated and any accompanying complications. 
Like many other suggestions in the literature, this guideline recommends using written 
reminders (text messages, letters, and email), phone calls from medical staff and/or autodialer 
messages, social media, or a combination of strategies. Since recommendations from this CPG 
were derived from nationally recognized experts based on research evidence, this piece of 
evidence was rated as high quality (Grade A). 
Construction of Evidence-based Practice 
Synthesis of Critically Appraised Literature 
 After a thorough review of the literature, five common themes were found. These themes 
include reminder/recall interventions, provider and patient-directed education, school-based 
vaccination, financial incentives/assistance, and designation of an immunization champion.      
 Reminder/Recall Interventions. Arguably one of the most cited interventions in the 
literature, reminder/recall interventions have been shown to significantly improve/increase 
vaccination rates all over the globe. Cutrona et al. (2018), used these interventions via the EHR 
patient portal and IVR calls.  These methods showed increases in vaccination uptake both when 
implemented independently and in combination with one another, compared to participants 
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receiving standard or usual care within the study. James (2018) also mentions reminder/recall 
strategies in her extensive evidence summary as an evidence-based method proven to increase 
vaccine uptake. Another JBI evidence summary conducted by Moola (2018) reviewed 
reminder/recall information specifically in the forms of person-to-person telephone calls, 
immunization reminder or recall letters, immunization reminder or recall postcards, text 
messages, immunization reminder or recall autodialer calls, a combination of letter or postcard 
plus telephone or autodialer calls, and provider reminders, combined with patient reminder or 
recall interventions. Although all of the reminder/recall interventions that the author analyzed 
proved to be statistically significant (RR 1.28; 95% CI 1.23 to 1.35), text message reminders 
showed the highest level of statistical significance and certainty among the included studies 
within this evidence summary (RR 1.29; 95% CI 1.15 to 1.44). The Region of Peel (2019) also 
endorsed reminder/recall interventions in their CPG detailing the use of mailed letters, 
telephone calls, and web-based reminders, as these strategies were found to be effective in the 
literature. In their systematic review, Abdullahi et al. (2017) analyzed 16 studies that 
incorporated reminder/recall interventions in the form of provider prompts and compared those 
strategies to patients receiving standard of care. Provider reminder prompts were found to make 
little difference in increasing the uptake of Tdap, influenza, HPV, or meningococcal vaccines. In 
their quasi-experimental study, Mazzoni et al. (2016) implemented a multifaceted intervention 
that tested the development of a reminder/recall program amongst five other evidence-based 
strategies. The combination of these strategies produced both statistically and clinically 
significant improvements in vaccination status. Influenza uptake rates went from 35.4% to 46% 
after the intervention. Tdap uptake increased from 87.6% to 94.5% in the post-intervention 
period, and HPV uptake also increased, as rates went from 7.1% to 23.7% after the 
intervention. Similar to Cutrona et al.’s study, Posadzki et al. (2016) systematically reviewed 132 
studies that implemented automated telephone communication systems (ATCS) to increase 
vaccination uptake. This reminder/recall intervention helped to improve adolescent vaccination 
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uptake rates, however, produced variable results in the adult population. In the study conducted 
by Molokwu et al. (2019), culturally tailored interventions were implemented in a largely 
Hispanic population to improve vaccination uptake of the HPV vaccine. This study also utilized a 
multifaceted approach, as it included the use of education, provider outreach, and assistance 
with access to vaccines. In this study, phone calls were implemented at 2, 4, and 6 months into 
the study to help remind patients about upcoming vaccine doses. Of the previously non-
vaccinated participants, adults produced a vaccination initiation rate of  77.4% compared to 
children at 55.8%. However, completion rates for the vaccine series only ended up being 31.6% 
for adults compared to 48.7% in children. Vann et al. (2018) also systematically reviewed 
interventions related to reminder/recall interventions for the uptake of vaccinations. Telephone 
and autodialer calls, letters, postcards, text messages, a combination of mail or telephone calls, 
or a combination of patient reminder or recall with provider outreach were all found to be 
effective interventions. Postcards, text messages, and autodialer calls produced the most 
significant findings when implemented alone amongst the different reminder/recall interventions. 
When combined, the effects of these interventions proved even greater effects than when used 
alone, thus supporting use for multicomponent intervention strategies within this systematic 
review. In their 2019 position statement, the American College of Obstetricians and 
Gynecologists endorsed paper and/or electronic reminders for providers. These reminders 
functioned to highlight opportunities for providers to vaccinate and catch patients while they 
were in the office, thus increasing the frequency of real-time vaccination uptake interventions. 
The Australian and New Zealand Society for Geriatric Medicine (2018) also mentioned 
reminder/recall interventions and recommended telephone calls or mailed letters as evidence-
based methods for promoting immunization in adults. Similarly, the National Institute for Health 
and Care Excellence (2018) also recommends these interventions in their CPG, along with text 
messages, letters, email, autodialer messages, social media, and/or a combination of 
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strategies. However, there are no specific guidelines for how often, these reminder modalities 
should be used, thus no specific recommendations regarding frequency is available at this time.  
 Education. In regards to providing education as a means of increasing vaccination 
uptake, James (2018) and The Region of Peel (2019) recommends providing patient-directed 
education in the form of brochures,mass-media campaigns, radio public service 
announcements, and websites. Abdullahi et al. (2017) suggest that simple, patient-directed 
vaccine-related information is effective at increasing uptake, however, this systematic review 
also noted that education that is complex or has multiple components was found ineffective at 
increasing vaccination uptake, and produced insignificant results (RR 0.98 
95% CI 0.96 to 0.99). This systematic review also concluded that provider-directed education 
coupled with performance feedback helped to increase HPV vaccination uptake by 5.7% for the 
initial dose. In relation to provider or staff-directed education, Mazzoni et al. (2016) tested a 
multimodal intervention consisting of stocking  vaccines in the clinics, modifying standing orders, 
developing a reminder/recall program, designation of an immunization champion, expansion of 
the payment assistance program, and staff education. Staff education was implemented in this 
study by having staff attend two separate training sessions, each focused on either HPV or 
Tdap vaccination during pregnancy. The sum of the study interventions produced significant 
results, with influenza vaccination uptake rates increasing from 35.4% to 46%. These methods 
also produced increases in Tdap uptake, as the rate went from 87.6% pre-intervention period to 
94.5% post-intervention. Increases in HPV uptake were also seen, as rates increased from 
7.1% to 23.7% after the study period. Molokwu et al. (2019) utilized education as a study 
intervention and found that providing educational materials in conjunction with other evidence-
based strategies significantly helps immunization rates. Specifically, these authors provided 
patient-directed education in both English and Spanish languages. The session went over 
information about cervical cancer, HPV transmission, HPV vaccine indications, series schedule, 
contraindications, and adverse reactions that could be expected. ACOG (2019) and the 
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Australian and New Zealand Society for Geriatric Medicine (2018) recommend evidence-based 
provider-focused education interventions such as educational forums, and direct provider to 
patient communication. Specifically, the Australian and New Zealand Society for Geriatric 
Medicine recommends that providers and other staff educate patients about the safety and 
efficacy profiles of each vaccine. Education regarding vaccination should be performed in-office 
and in real-time according to the Australian and New Zealand Society for Geriatric Medicine. 
Unlike many other sources, patient education regarding vaccination is preferred to take place in-
person, for a more direct patient-provider interaction.  
 School-based Vaccination. According to The Region of Peel (2019), school or class-
based vaccination has been shown to significantly impact vaccination rates in school-aged 
individuals, specifically females in the sixth and seventh grades. Abdullahi et al. (2017) also 
synthesized evidence in the literature to support class or school-based vaccination, as it was 
found to increase vaccination rates by 1.09 (95% CI 1.06 to 1.13). 
 Financial Incentives/Assistance. Assistance with covering the costs of vaccines, or 
simply being rewarded monetarily was another common theme found within the literature to 
increase vaccination rates. Abdullahi et al. (2017) analyzed how effective financial incentives 
were in the form of shopping vouchers on vaccination completion. Unsurprisingly, financial 
incentives proved to increase uptake by nearly one and a half times (95% CI 1.05 to 1.99). In 
the study conducted by Mazzoni et al. (2016), patients experienced significantly higher vaccine 
rates after adjustments to the already in place payment assistance program was made. 
Essentially, after revamping this assistance program to include the other participating clinic in 
the study, participants who were uninsured produced a spike in vaccination rates from 7.6% 
before to 24.3% and from 6.5% before to 22.3% in the underinsured. Similarly, Molokwu et al. 
(2019) provided free vaccines for qualifying participants as a part of their multimodal 
intervention.  
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 Designation of an Immunization Champion. Another common theme found within the 
literature involves assigning staff or clinic members to the role of immunization champion. 
According to Mazzoni et al. (2016), the immunization champion in this study was a registered 
nurse who served to perform chart audits and provide real-time feedback to providers and staff 
about missed vaccination opportunities and recommendations for improvement. ACOG (2019) 
also recommends the implementation of an immunization champion. In addition to providing 
feedback, they recommend the immunization champion to be responsible for ordering, 
receiving, and ensuring vaccines are kept and stored and appropriately within the facility.  
Best Practice Model Recommendation 
 The recommendation for best practice has been derived strictly from the literature.  
According to this evidence, and the number of significant results found for multiple interventions, 
it was found that increasing vaccination uptake is best tackled using a multi-component 
strategy. When reviewing the literature, the two most effective strategies include reminder/recall 
interventions and patient-directed education. Since the vaccination gap in the general 
population is increasing, implementing these simple, yet effective strategies is of paramount 
importance for both the health and safety of pregnant women and their fetuses (Baggio & 
Gétaz, 2019). This combination of interventions has been shown in the literature to repeatedly 
produce significant results and improve vaccination status worldwide. Reminder/recall 
interventions in the form of phone calls, text-messages, postcards, letters, automated 
messages, social media, and email have produced significant results in a majority of the articles 
reviewed in this project. Of these interventions, text-message and telephone calls show the 
highest rate of vaccination uptake in the literature (Australian and New Zealand Society for 
Geriatric Medicine 2018; Moola 2018; Vann et al., 2018). Although reminder/recall interventions 
have proven to be the most effective intervention for vaccination uptake in the literature, a 
majority of the evidence includes educational efforts in regards to vaccination uptake. Education 
done via simple measures such as face-to-face communication, written mail, telephone 
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conversations, presentations, printed materials, and websites should be chosen over more 
complex methods, as this has been statistically shown to produce greater outcomes (Abdullahi 
et al., 2017; American College of Obstetricians and Gynecologists, 2019 Australian and New 
Zealand Society for Geriatric Medicine, 2018; Cutrona et al., 2018; James, 2018; Mazzoni et al., 
2016; Molokwu et al., 2019; Region of Peel, 2019; The National Institute for Health and Care 
Excellence, 2018). Although vaccination education can be delivered through multiple modalities, 
face-to-face education could be viewed as easier and more cost-efficient to implement, as it 
does not require the purchase or distribution of additional educational materials. Furthermore, 
face-to-face education provides patients the opportunity to express concerns and ask questions 
in real-time, further strengthening patient rapport (Posadzki et al., 2016; The National Institute 
for Health and Care Excellence, 2018. These methods have shown the best evidence in regards 
to increasing vaccination uptake, and thus should be considered in order to increase 
immunization rates in the unvaccinated and under-vaccinated, and ultimately close the 
vaccination gap among pregnant women. These interventions derived from the literature will 
help to further highlight and address the vaccination gap and provide easy, yet effective means 
to improving vaccination rates. Simple measures such as reminder/recall strategies have been 
shown throughout the literature to be effective in various populations, thus this intervention 
strategy will be implemented into a women’s health clinical facility in hopes of reciprocating the 
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
A multicomponent strategy including patient-directed vaccination education and 
automated text-message and/or reminder phone calls was implemented in a maternal health 
office. The implementation phase of this project took place over the period of 14 weeks. The 
purpose of this combination of interventions was to measure the effectiveness of these 
strategies on increasing uptake of Tdap and influenza vaccination in the pregnant population.  
Participants and Setting 
 The implementation phase of this project was performed at one facility located in the 
northern region of Indianapolis. This clinical facility specializes in midwifery and is equipped with 
five in-house CNMs, with three of those providers holding doctoral degrees. In addition to 
providers, this facility is also staffed with two medical assistants (MAs) and two RNs. Of the four 
CNMs at the clinic, there is over 50 years of combined experience as four of the providers are 
senior-level practitioners holding over 15 years experience each. The newest CNM at the clinic 
has just over 6 years of experience. The population that the clinic serves is primarily of the white 
race, over the age of 25, married, and possess commercial insurance (L. Kendrick, personal 
communication, 2020). The clinic averages about 25 patients a day with a little over half of 
those appointments requiring prenatal care to some degree (L. Kendrick, personal 
communication, April 16, 2020). As of January, 2020, there were 35 pregnant patients being 
seen at this clinic. Furthermore, this clinic has also seen an increasing number of first-time 
mothers, as the practice of midwifery becomes better known and trusted among mothers and 
mothers-to-be in the surrounding area (L. Kendrick, personal communication, April 16, 2020). 
Thus, patients being seen by all CNMs at the clinic were recruited in order to obtain  a larger 
sample size. Patients under the age of 18, those with immune-related illnesses, or those with 
allergies to either the influenza vaccine or the Tdap vaccine werel be deemed ineligible for 
participation.  
EBP PROJECT            57 
 
Pre-Intervention Group Characteristics 
 Due to COVID-19, providers at the clinic were practicing on a rotating basis, having only 
one provider in-office at a time to see patients up until December of 2020. Thus, each provider 
would go to the clinic one day a week to see patients, perform tele-health appointments the 
remaining business days, and attend live births on the other days of the week. During that time, 
physical office appointments were limited, which could have possibly impacted the amount of 
patients who planned to come in for vaccination visits. The practice flow for pregnant patients 
consists of them being checked in by the front office staff, being seen and having vitals collected 
by nursing personnel such as the MA or staff RN, and being seen and assessed by the CNM. 
After performing an individualized assessment, answering patient related questions/concerns, 
and collecting pertinent labs or tests, patient education was performed on each topic covered 
during a patient's visit and appropriate vaccines were offered at this time. Along with in-person 
education and verbal offers, hard-copy handouts published by the CDC were given out to 
patients that detail the benefits of both influenza and Tdap vaccines for pregnant women and 
fetuses. After the initial offer, no further follow up was scheduled or anticipated by the patient. 
The vaccine protocol was rather vague and non-specific, as there was no measurable goal set 
forth regarding the number of pregnant patients to be vaccinated within the clinic. 
 
Intervention 
 Preparation and planning for this DNP project was guided by the Iowa model for 
evidence-based practice. After conducting a facility assessment to determine specific 
population-based needs, confirmation was made that vaccination uptake was a high priority at 
the clinical agency. Thus, a literature search was performed to identify scholarly literature and 
evidence was gathered and appraised to determine quality and evidence level. After forming a 
clinical team, the evidence was then synthesized to determine the best available practice 
recommendations.  
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 The standard of practice for offering and promoting vaccination within the clinic was 
verbal and written, in-person education. This practice consisted of a verbal offer at 27-36 weeks 
gestational age for the Tdap vaccine and at the next office visit immediately after the seasonal 
influenza vaccines arrived. The initial vaccine offer is followed up with a brief overview of the 
material presented on a hard copy hand-out regarding vaccination safety and importance 
sponsored by Centers for Disease Control (CDC). This practice strategy, while it does utilize 
best practice techniques such as simple education, is lacking the multicomponent aspect that 
could help to boost vaccination rates. A reminder/recall component was added to the current 
vaccination regime practiced at the office, and the implementation of reminder text-messages 
and/or phone calls served as the primary intervention.  
 After assessing allergies/adverse effects in all participants who were at least  27 weeks 
gestational age, the Tdap vaccine was offered. Standard of practice education took place at this 
time which included a brief overview of an evidence-based hand-out outlining the importance of 
prenatal/maternal vaccination for influenza and Tdap vaccines. At 24 weeks gestational age, 
participants received either a text-message or phone call (based on communication preference) 
once per week with a simple reminder message stating, “You are almost due for your Tdap 
vaccine! Please make sure to schedule your vaccine by or at your next office visit!”. Participants 
continued to receive one text-message and/or phone call per week until receipt of vaccination 
took place and was documented. If vaccination uptake had not been documented by 36 weeks, 
no further interventions were implemented. Similarly for the influenza vaccine, participants 
received a text-message and/or phone call (based on communication preference) once per 
week as soon as the clinic received the first shipment of seasonal influenza vaccines which was 
in early October 2020. This message stated: “You are due for your seasonal influenza vaccine! 
Please make sure to schedule your vaccination by or at your next office visit!”. Participants 
continued to receive one text-message/phone call per week until receipt of vaccination took 
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place and was documented. If vaccination uptake did not take place by the 10th week of the 
project, no further interventions were implemented.  
Comparison  
 Compared to the current standard of practice which included simple face-to-face 
education, participants were better held accountable for the combined health of themselves and 
their fetuses using weekly reminder/recall strategies of each woman’s preference coupled with 
patient-directed education. While the educational component will remain the same, the 
supplementation of either text-message and/or phone call reminders will only serve to keep the 
idea of vaccination fresh on participants’ minds on a weekly basis. The idea of a steady and 
constant communication system in place to bring attention and awareness to the importance of 
vaccination was expected to improve uptake rates. By connecting with participants on such a 
consistent basis, vaccination uptake was put on the forefront of participants' minds and helped 
to establish vaccination as an on-going priority throughout the duration of pregnancy, instead of 
just at the initial offer.  
To replace the practice policy in place, a new strategy was presented to the clinic staff 
and tried during the pilot phase as indicated by the Iowa model to assess any barriers or 
modifications that needed to be made prior to the final practice change. The new practice 
change detailed in the previous paragraphs was placed in respective employee work rooms. 
Both nursing staff and providers had their own practice change alert reminders posted in high 
traffic areas for each profession. Nursing staff were made responsible for collecting phone 
numbers (with capability of receiving phone calls or text message) at the end of the initial visit in 
which vaccination against either influenza or Tdap was offered. Amongst all of the nursing staff, 
one individual was chosen to input phone numbers into the digital application for future 
automated texting and/or calling, as modeled in the literature as a change champion. At the 
previously mentioned time intervals, the change champion scheduled either the automated text-
message or phone call reminder, and consequently monitored the EHR for documentation of the 
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completion of either the influenza vaccine, Tdap vaccine, or both, until completion of the project 
timeline. In order to sustain this policy change, a long-term subscription with the automated 
communication platform was purchased by the clinic, and a role title was created in order to 
recognize the individual who would now become responsible for performing the reminder/recall 
interventions on a daily basis. This new role was denoted as, “vaccine champion” and was 
assumed by one of the clinic staff who performed data entry and monitoring during the project 
period, thus she was already very familiar with the platform and prepared to continue the duties.    
Outcomes 
 The primary outcome of this DNP project is to evaluate the percentage of vaccination 
uptake among pregnant women after the intervention. This outcome was evaluated by 
performing chart audits on each eligible participant both during the intervention period and at the 
end of the 14 week period. These chart audits revealed the number of participants who became 
vaccinated with either the influenza vaccine or the Tdap vaccine during the project period and 
the number of those who did not become vaccinated. Secondary outcomes include the overall 
percentage of participants who became ill with either influenza or pertussis  and what 
percentage of those individuals received prior immunization.  
Time 
 The implementation phase of the project began on October 15th, 2020, as this time 
coincided with the arrival date of the first shipment of influenza vaccines. This project took place 
over the course of 14 weeks, as this time period served as an ample opportunity for influenza 
vaccination uptake within the prime of flu season. Furthermore, since Tdap vaccination is 
indicated between 27 and 36 weeks gestation, a 14 week time frame was adequate to offer and 
provide the vaccine throughout the entirety of the indicated period (9 weeks).   
Protection of Human Subject  
 Prior to the implementation phase of the project, ethics and privacy certification was 
obtained through the Collaborative Institutional Training Initiative (CITI) program. Furthemore, 
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the Valparaiso University Institutional Review Board (IRB) was also consulted to approve the 
nature of the DNP project and approve the level of clearance needed based on the level of risk 
assigned to the project. Only after confirmation from both the Valparaiso IRB and the faculty 
advisor, was the project launched. Chart access was granted via an in-person training hosted by 
the affiliated health care corporation and log-in credentials will be kept in a secure off-site 
location. Chart audits will be conducted only while on a secure network, and in the privacy of a 
secured office environment. No patient identifiers will be stored after the duration of the project, 
and a confidentiality contract will be signed prior to initiation of the intervention. After the study 










The purpose of this DNP project was to utilize a variety of evidence-based interventions 
to implement a policy in an urban/suburban region located near northern Indianapolis to  
increase vaccination uptake among pregnant patients. This project specifically looked to 
increase vaccine uptake for  seasonal influenza and Tdap. This was undertaken by providing 
pregnant patients who presented to a midwifery clinic in Indianapolis, Indiana, with in-person 
education consisting of reputable hand-out information from the CDC, coupled with weekly 
reminders in the form of either text-message or phone call, based on participant preference. 
After agreeing to participate, participants elected to receive either a text-message, or phone call 
on a weekly basis until completion of either/both vaccines, or until the end of the project period. 
Once documentation of a completed influenza or Tdap vaccine was observed in the EHR, text-
messages/phone calls ceased to be made. The projected outcome for these interventions was 
to observe increased vaccination uptake within the practice, as mentioned in the PICOT 
question. Secondary outcomes assessed the number of patients who contracted either 
influenza or pertussis during her pregnancy in relation to vaccination status throughout the 
project period.  
Participants 
The sample for this DNP project consisted of 34 pregnant patients, all residing in the 
surrounding Indianapolis area who received prenatal care at the site of implementation. The 
initial goal was to have at least 50 participants, however constraints due to the on-going 
pandemic affected the number of patients who were allowed to  visit the clinic at a time. Half of 
the participants were married, while the other half were unmarried. Those that self classified as 
unmarried labeled themselves as  in a relationship, or without a romantic partner completely. A 
majority of the participants, specifically 41.2% (n=14) were between the ages of 15-30 years 
old. Twelve of these participants were between the ages of 30 and 45 (35.3%), while only eight 
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were over the age of 45 years (23.5%). Of the participants, 20.6% (n=7)were pregnant for the 
first time, while 32.4% (n=11) were on their second pregnancy and another 32.4% (n=11) were 
on their third pregnancy. Lastly 14.3% (n=5) were on their fifth pregnancy at the time of the 
intervention.  Slightly over a quarter of the sample population, or 26.5% had attained their 
bachelor’s degree(n=9). This made up a majority of the sample. On the other hand, only 8.8% 
(n=3) of the participants were educated at the doctoral/professional level. Only 17.6% (n=6) of 
the participants had attended some high school, while 23.5% (n=8)  had only completed high 
school. Those with graduate degrees comprised 11.8 % (n=4) of the sample population. Those 
who completed trade schooling or some other form of alternative education made up 5.9% (n=2) 
of the sample collectively.  
A majority of the sample, or 29.4% was made up of participants who made between 
$25,000-$50,000/year (n=10) . Seven participants (20.6%) made less than $25,000/year, 
23.5%(n=8) made between $50,000-$100,000/year, 17.6% (n=6) made between $100,000-
$200,000/year, 5.9% (n=2) made over $200,000/year, and 2.9%(n=1)  preferred not to disclose 
this information. 
Slightly over a quarter of participants (26.5%) were of African American descent (n=9), 
17.6% were of Asian descent, 17.6% (n=6)  were of Caucasian descent (n=6), 11.8% were of 
American Indian or Alaskan Native descent (n=4), 8.8% were of Hawiian or Pacific Islander 
descent, 8.8% were of Hispanic heritage (n=3), and another 8.8% identified as another unlisted 
race (n=3). See Table 4.1.  All participants who began the project completed it, thus no attrition 
was observed. Completion of the project was considered as continuing to receive text-
messages/phone calls for the entire duration of the project without choosing to opt out, or 
without electing to stop receiving reminders. 
 Information regarding prior uptake of either the influenza or Tdap vaccine was collected 
prior to the intervention. Prior to the intervention, 73.5% (n=25) of participants admitted that they 
had received the influenza vaccine in the last 365 days, or the last flu season. Even though they 
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had received a vaccine for influenza in the last 365 days, another influenza vaccine was still 
indicted at this time, as each year the influenza strains differ.  Similarly only 26.5%  (n=9) had 
admitted to refusing or missing the influenza vaccine within this same time-frame. Meanwhile, 
85.3% of participants admitted to receiving their Tdap vaccine either in their last pregnancy or at 
the time that the last booster vaccination was due, for example, after ten years. Nine, or 14.7% 
of participants denied either receiving the Tdap vaccination during their last pregnancy, or at the 
time the last booster vaccination was due. Thus, it is clear from the data that more participants 
began the project with having received their Tdap vaccine (85.3%), as compared to the 





EBP PROJECT            65 
 
Figure 3.1 
Participant Demographics- Marital Status 
 
Figure 4.1 
Participant Demographics- Age 
 
Figure 5.1 
Participant Demographics- Income 
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Figure 6.1 
Participant Demographics- Times Pregnant  
 
Figure 7.1 
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Figure 8.1 
Participant Demographics- Previous Influenza Vaccine Uptake 
 
Figure 9.1 











Changes in Outcome 
 To determine the significance of all outcomes, data were entered and analyzed using the 
International Business Machine (IBM) statistical analysis program, SPSS. Baseline data were 
obtained from all participants via an in-office paper survey. Over the project period, vaccination 
uptake was closely monitored by the project leader and clinic personnel via the EHR. Once 
vaccination was complete, documentation of which vaccine was given, the route of the injection, 
dose, location, and lot number and expiration number were recorded. Secondary outcomes 
were defined by the documentation of a verified positive influenza test or confirmation of the 
pertussis bacterium within the EHR.  
Statistical Testing and Significance  
Effectiveness of the combination of interventions was evaluated for statistical 
significance of the proposed PICOT question using a paired sample t-test. Secondary analysis 
using chi-square analysis was performed to evaluate the differences in demographic data 
variables amongst the participants. A paired sample t-test was performed in order to assess the 
mean difference in vaccination uptake among participants prior to the intervention and post-
intervention. The mean number of participants who admitted to receiving an influenza vaccine 
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prior to the intervention was not statistically different from the mean status post intervention (M 
= 0.117, SD = .64). Similarly, the paired sample t-test did not reveal a statistically significant 
difference between pre-intervention uptake of the Tdap vaccine (M = .029, SD = .45) from post-
intervention uptake of the Tdap vaccine.  
Table 3.1 
 Mean Comparison of Influenza and Tdap Vaccination Prior to and After the Intervention 













.11765 .64030 .10981 -.10576 .34106 1.071 33 .292 
Tdap vaccine .02941 .45960 0.7882 -.13095 .18977 .373 33 .711 
 
Chi-square tests of independence were performed to compare the frequency of 
demographic data variables of participants in relation to vaccination uptake prior to the 
intervention and after the intervention. Variables assessed include marital status (X2 (1)= .234, 
p>0.05) race (X2 (1)= 16.3, p<0.05), income (X2 (1)= 10.8, p<0.05), education (X2 (1)= 15.6, 
p<0.05), number of times pregnant (X2 (1)= 1.7, p>0.05), number of independents (X2 (1)= 3.3, 
p>0.05), and prior uptake of either the influenza vaccine (X2 (1)= 0.38 p>0.05) and/or Tdap 
vaccine (X2 (1)= 2.1, p>0.05). A significant difference was found amongst those with higher 
education levels and vaccination uptake for pertussis, as those with higher levels of education 
were more likely to have received their Tdap vaccine in the past. Race also produced a 
statistically significant difference amongst those participants who chose to become vaccinated 
for pertussis both before and after the intervention, in that minority groups such as 
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Hawiian/Pacific Islanders, African Americans, and Hispanics were less likely to have received 
their Tdap vaccine when compared to other races. Chi-square tests also determined that there 
was a significant difference between income level and Tdap vaccination uptake. Only those who 
made $25,000-$50,000, or over $200,000 a year were the only groups of participants who did 
not choose to become vaccinated against pertussis. For the influenza vaccine, there were no 
significant differences amongst the demographic variables.  
Table 4.1  
Chi-Square Analysis of Prior Tdap Vaccination and Education 





15.619 6 .016 
 
 
Table 4.2  
Chi-Square Analysis of Prior Tdap Vaccination and Education 





16.284 6 .012 
 
 
Table 4.3  
Chi-Square Analysis of Prior Tdap Vaccination and Income 
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The purpose of this EBP project was to evaluate the effectiveness of a policy 
implementation that initiated a combination of evidence-based patient education and 
reminder/recall interventions in the form of text-messages and/or phone calls in efforts of 
increasing vaccination uptake for both influenza and pertussis in pregnant patients. Patient 
education was performed using evidence based hand-outs during in-person clinic visits where 
providers took extra time to thoroughly review the literature regarding the benefits of maternal 
vaccination, as well as to answer any patients questions or concerns related to vaccine safety 
and efficacy. Reminders were sent out via automated text-message or phone call based on 
participant preference. Contraction of either the influenza virus or pertussis during the project 
period was measured as a secondary outcome measure.  
Explanation of Findings 
 The PICOT question, “In pregnant women, how do reminder/recall interventions and 
patient-directed education compared to standard practice affect vaccination uptake rates within 
12 weeks?” was answered by measuring vaccination uptake rates for both the influenza vaccine 
and the Tdap vaccine both prior to and after the intervention. Of the participants who received 
an influenza vaccine during the prior flu season, 69% also went on to receive their influenza 
vaccine during the project period (post intervention). Of those participants who received either 
their last indicated Tdap booster, or received a booster during their last pregnancy, 89.7% also 
went on to receive their Tdap vaccine during the project period. Overall, there was a higher 
uptake rate of the Tdap vaccine amongst the participants compared to influenza vaccination. 
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When comparing mean pre-intervention vaccination uptake rates to post-intervention 
vaccination rates using paired sample t-tests, there was no significant difference found, p>0.05).  
Participants who held bachelor's degrees or higher (graduate, professional,or doctoral) 
made up the percentage of participants who chose not to receive their Tdap vaccination during 
the project period (post-intervention), in relation to education level. Those who identified as 
Hawiian/Pacific Islander or Hispanic were least likely to receive their Tdap vaccines after the 
intervention. Only 33.3% of Hawiian/Pacific Islanders and 33.3% of Hispanics received their 
Tdap vaccines post-intervention, compared to other races. Furthermore, only 50% of 
participants who made over $200,000 (individually; not per household) or more a year, and 60% 
who made $25,000-$50,000 a year went on to receive their Tdap vaccine after the intervention.  
 These results, while clinically significant, were not consistent with results of similar 
projects in the literature and other research studies. Of the studies reviewed in chapter two, 
many of them included expanded strategies for reminding patients to schedule vaccine visits. Of 
the literature analyzed in this EBP project, less than half of the studies utilized postcards or 
mailed items to remind patients to receive their indicated vaccines. While this EBP project did 
not utilize this method of communication to remind patients to receive their vaccines, a 
multimodal approach using both text-message/telephone reminders coupled with in-person 
education on a weekly basis for 14 weeks was implemented, as these two interventions showed 
the highest efficacy for increasing vaccination uptake within the current literature. The reason for 
this inconsistency could be attributed to a variety of factors. For example, much of the research 
regarding increasing vaccination uptake rates was conducted on either the general population, 
or specific, unrelated populations such as pediatrics or geriatrics, and not specifically pregnant 
women. Furthermore, studies within the literature assessed a vast amount of vaccines, and not 
just influenza and pertussis, thus possibly causing inconsistencies in outcomes due to the 
varying levels of perceived risk for different vaccines. Additionally, the time in which the 
intervention took place was in the midst of a global pandemic, thus the clinic was performing 
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more virtual appointments than usual, and patients were less willing to physically come into the 
office for appointments. Furthermore, the small sample size was likely due to the environmental 
factors that were occuring at the time of the EBP project.  
Secondary outcomes measured the percentage of participants who contracted either 
influenza or Tdap in relation to vaccination status. Of all 34 participants who enrolled and 
completed the project, zero contracted either illness during the project period. This outcome was 
measured with assistance from the EHR. After the 14 week  project period, the EHR was 
thoroughly searched for all enrolled participants for documentation of a positive influenza test, or 
diagnosis of influenza, or a diagnosis of pertussis. While uptake of both influenza and Tdap 
vaccines were not  successfully met at 100% completion rate, none of the participants suffered 
adverse effects due to contraction of either illness. 
Unexpected findings for this project were the rates of Tdap vaccination amongst those 
participants who had higher levels of education. As mentioned above, those participants holding 
bachelor's degrees or higher, were less likely to become vaccinated against pertussis. This 
finding was not anticipated, as this demographic statistic is not consistent with the literature, as 
those with higher levels of education were shown to be more likely to become vaccinated in 
other studies as discussed in the literature review. 
 Theoretical Framework 
The theoretical framework used for this EBP project was Nola J. Pender’s health 
promotion model. This model was chosen based on its relevance to the project purpose, as it 
focuses on individual characteristics and experiences, behavior-specific cognitions and affect, 
and behavioral outcomes as they relate to health promotion, and overall wellness (Petiprin, 
2020). Thus, the overall purpose of this theoretical model is to increase a patient's sense of 
well-being and health. This theoretical framework was also chosen based on its focus on 
individuals’ personal characteristics that make each person behave differently, in regards to 
health behaviors. Since the overarching goal, or theme of this framework is to increase wellness 
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and good health, it was fitting to guide this project, seeing as though vaccination is a form of 
primary prevention for many different illnesses.  
The health promotion theoretical model makes four assumptions. The first assumption is 
that individuals seek to self regulate their behavior (Petiprin, 2020). In other words, individuals 
strive to take control of their own lives, and make their own active health decisions. The second 
assumption that this framework makes is that individuals interact with their environments, which 
transforms the environment, as well as the individual themself (Petiprin, 2020). The third 
assumption of this model is that healthcare professionals, such as nurses directly influence 
patient’s lives and decisions, as they are part of their interpersonal environment, which 
ultimately affects people throughout the lifespan (Petiprin, 2020). Finally, the last assumption 
this theoretical framework makes is that self-initiated reconfiguration of the person-environment 
interactive patterns is essential to changing behavior (Petiprin, 2020).  
The strengths of this theoretical framework include its ability to address individuals' own 
personal behaviors and how they relate to their health status along with how past behaviors, 
and their frequency affect future behaviors. Seeing as though the purpose of this project 
focused on primary prevention and reducing adverse effects from influenza and pertussis 
amongst pregnant women, this theoretical model was very fitting.  
A weakness of this model is that it does not take into account the indications in which a 
person is unable to perform health sustaining behaviors. Since this theoretical framework 
considers health promoting behaviors as the end-point for health promotion, it fails to take into 
consideration those individuals who cannot partake in such behaviors due to direct 
contraindications, religions, personal beliefs, or current health status. For example, those who 
were allergic to either vaccine, declared as immunocompromised, or otherwise inappropriate to 
receive either vaccine were not eligible for participation in the project, and thus this framework 
was unable to be applied to this population.  
EBP Framework 
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The EBP framework, or model used for this project was the Iowa Model. This model was 
selected based on its usefulness in implementing EBP for clinicians who are just beginning, or 
unfamiliar with the process of implementing evidence based interventions. It was also selected 
for use due to the inclusion of a pilot stage, allowing change agents to modify and realign the 
proposed intervention with project goals prior to the final intervention. This model uses a step-
by-step approach to implementing evidence based practice. The first step of the Iowa model is 
to identify an area of practice that warrants a practice change, or modification. Next, it is the 
responsibility of the change agent to use clinical reasoning to determine if the selected problem 
at hand is of enough importance and priority to the organization to pursue. The next step in the 
Iowa model is to gather individuals in order to develop, evaluate, and implement the EBP 
change. After this is done, the next step is to gather and analyze the evidence related to the 
practice change and then develop a PICOT question. Once evidence has been gathered, the 
change agent should then critique and synthesize the evidence. If there is enough evidence to 
justify a practice change, progression to the next step may occur. After the desired change has 
been justified by both the project leader and key stakeholders as a priority and a vital way to 
improve organizational success, the next step involved is to conduct a pilot study. This means 
that parts of the overall intervention will be implemented on a smaller scale, in order to assess 
effectiveness, and determine what modifications need to be made when conducting the final 
change. Lastly, it is important to always evaluate the effectiveness of the intervention. During 
this phase, evaluation of feasibility and appropriateness should occur before decisions are 
made to implement the intervention across other departments/units/organizations.  
Strengths of this model include the use of a pilot phase, especially for those individuals 
who are new to EBP, or who have never implemented a project before. This was considered a 
major strength, as this time period allowed the project facilitator to better judge the feasibility of 
the intervention prior to fully implementing it. During this period, only one patient per day was 
invited to participate in the project. This was done to determine both the likability and usability of 
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the evidence based educational hand-out used for patient education, and to allow clinic staff 
enough time to configure the digital application for sending automated reminders. Clinic staff all 
took turns using the digital application and practiced sending out trial text-messages to their own 
cellular phones to ensure that the program sent messages quickly and in the correct format. 
Likewise, staff members practiced scheduling phone calls using their own cellular phones and 
listened to the message to ensure that the automated voice was clear, audible, and spoke at an 
appropriate speed so as to ensure maximal efficacy of this intervention.   
One weakness of this model is that it does not address what would be the final step in 
implementing EBP, maintaining the practice change. While it does encourage clinicians and 
implementers to disseminate results/findings, it does not specifically state any mechanisms in 
order to sustain a practice change. Seeing as though the ultimate goal is to share evidence 
based data with other like-minded peers, this EBP model lacks the ability to ensure that 
clinicians and other healthcare professionals alike are  being consistent with their interventions, 
in order to produce sustainable outcomes for both patients and staff.  
Modifications that were made during the pilot phase consisted of adding more time to 
patient appointment visits to account for dedicated time for patient education and collection of 
contact information for reminder/recall interventions. Providers and patients collectively voiced 
an appreciation for the additional time set aside for patient education, as well as time for patient 
questions and concerns to be addressed. Additionally, one clinic staff member was dedicated to 
perform data entry into the digital application in order to send out automated text-messages 
and/or phone calls. This was decided after the initial pilot phase, as there were inconsistencies 
in usage of the digital application amongst staff members. 
 When considering future implementation of a similar project, modifications that would be 
made include initially designating one clinic staff member to be in charge of entering phone 
numbers into the digital application for automated reminders. This should be done for efficiency, 
as well as consistency in the use of the application. Further modifications would be to add a 
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third reminder/recall format such as a mailed postcard, or email reminder. As evidenced in the 
literature, communication in the form of various styles (text-message, telephone call, email, 
postcard, patient portal reminder, etc.) helps to increase vaccination uptake, especially when 
combined.  
Strengths and Limitations of the DNP Project 
Strengths 
 Although the sample size was small, there was no attrition for this EBP project. All 34 
participants who enrolled in the project completed the project throughout its entire duration (14 
weeks). Additionally, appreciation was voiced by both providers and patients regarding the 
extended appointment times for patient teaching. Providers mentioned that the additional time 
spent with patients allowed for rapport building, as well as the opportunity to provide 
reassurance to concerned patients regarding the safety and efficacy of both the influenza and 
Tdap vaccine. Patients mentioned that they felt as though the additional time at the end of 
appointments was useful, and helped them feel more comfortable about receiving vaccinations 
during pregnancy. Furthermore, patients voiced that the educational hand-out received clear 
and succinct information, without the use of medical jargon, or “pushy” language. Lastly, 
although the results were not found statistically significant, vaccination uptake rates did not 
decrease from the clinic’s prior year’s average vaccination uptake rate. Thus, the intervention 
did not have a negative impact on vaccination uptake at the clinic. 
Limitations 
 The small sample size could likely be contributed to the changes and modifications to 
clinic procedures during the global COVID-19 pandemic. Since an effort was made to practice 
social distancing, even in health care environments, clinic appointments were restricted and 
limits were placed on the number of occupants in the building at any given time. Due to this, 
additional time was already implemented into the clinic procedure for more thorough disinfecting 
and sanitizing of all equipment before and after each appointment, and thus reduced the 
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number of overall patients seen per day at the clinic. Further, there was some initial lag in 
recruitment, as the initial consent form was rather lengthy, making it less likely that patients 
would read it, let alone agree for participation in the project.  
 
Implications for the Future 
After conducting this EBP project and observing the overall effects of the reviewed 
interventions, there were many implications for future research and practice observed. These 
implications fall into the category of clinical practice, EBP, research, and education.  
Practice 
Based on both patient and provider feedback, it was determined that clinic routine will be 
changed indefinitely to accommodate new procedures for promoting vaccination uptake. One 
staff member should be designated for usage of the digital application, as this was found to  
keep use consistent during the project period, and reduced the time needed for orienting other 
staff members on how to use the application as frequently. Further, additional time should 
continue to be incorporated into office visits to allow for patient education and entry of 
communication preferences into the digital application.  
EBP Model 
The Iowa model was found to be very effective and relevant to guide this EBP project. 
This model is a great tool for clinicians who are new to EBP, as it utilized a pilot phase to 
essentially test the intervention on a smaller scale for deficiencies or areas of improvement prior 
to performing the full scale practice change. This aspect of the model served especially useful 
for this EBP project, as this site had never previously completed EBP, nor any formal quality 
improvement projects. The pilot phase helped both the project facilitator and staff adjust to the 
proposed change, and make corrections as seen necessary for the clinic staff.  
Research 
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 Due to the limited number of research articles specifically targeted towards pregnant 
women and vaccination uptake strategies, further research on this population would be helpful. 
Much of the research was geared towards the general population, pediatrics, or geriatrics. Since 
pregnant women are a vulnerable population, limited research evidence involving vaccine 
uptake strategies were found. Attempts at future research should explore additional barriers to 
vaccination within this population, as well as additional strategies targeted towards these 
individuals that would assist in increased vaccination uptake. For example, reminders/recalls in 
this population could be given in the form of calendars, specifically for pregnancy that could 
include appointments, indicated tests/screenings, reminders, fetal growth benchmark statuses, 
and much more.  
Education 
 Seeing as though education was a major component of this EBP project, education will 
need to continue to occur at the end of patient appointments using the evidence-based hand-
outs that patients can then take home and keep for review. More importantly the effectiveness 
of APRN led patient education was highlighted throughout this EBP project. With the aid of 
additional time during appointments, provider-led education was found to help build rapport with 
patients and also help patients to feel more at ease when making the decision to become 
vaccinated. Specific time set aside for education should continue to be incorporated into the 
clinic’s routine, as this helped patients to feel a more personal connection to their providers, as 
well as a sense of comfort knowing that their providers cared for them enough to sit down and 
discuss vaccination, as well as address any concerns, or questions that the patient may have.  
Conclusion 
This EBP project, while not found statistically significant, was found helpful to the clinic. 
This project helped to highlight the ease of some very basic interventions to help increase and 
sustain vaccination uptake amongst pregnant women by using commonly used communication 
modalities such as text-message and telephone. This EBP project not only modified clinic 
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procedure, but also helped to broaden the perspective of the patients visiting the clinic regarding 
the importance of vaccination during pregnancy. Further, providers at the clinic were better set 
up to initiate patient education sessions, and attend to patients needs more efficiently. All in all, 
this EBP project was considered successful by clinic staff, and efforts to sustain this practice 
change were put into place prior to termination of the project to ensure a smooth transition for  
the permanent policy adjustment.  This was done by designating a single individual to input 
communication data into the application. Due to the ease and familiarity of digital applications to 
many, the use of this intervention may easily be translated to other clinics, and even other 
disciplines as well. 
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ACRONYM LIST 
ACOG: American College of Obstetricians and Gynecologists 
APRN: Advanced Practice Registered Nurse 
ATCS: Automated Telephone Communication Systems 
CDC: Centers for Disease Control 
CINAHL: Cumulative Index of Nursing and Allied Health Literature  
CITI: Collaborative Institutional Training Initiative  
CNM: Certified Nurse Midwife 
DNP: Doctor of Nursing Practice 
EBP: Evidence-Based Practice 
EHR: Electronic Health Record 
FNP: Family Nurse Practitioner 
HCP: Health Care Professionals 
HPV: Human Papillomavirus 
IBM: International Business Machine 
IRB: Institutional Review Board 
IVR: Interactive Voice Response 
MA: Medical Assistant 
RN: Registered Nurse 
PCP: Primary Care Provider 
WHNP: Women’s Health Nurse Practitioner 
JBI: Joanna Briggs Institute 
RCT: Randomized Controlled Trial 
Tdap: Tetanus, diphtheria, acellular pertussis 
TRIP: Turning Research Into Practice 
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